Literature DB >> 3859296

Induction of haemoglobin synthesis in the human leukaemia cell line K562 by monomethyltriazenes and imidazotetrazinones.

M J Tisdale.   

Abstract

The effect of a group of imidazotetrazinones and alkyltriazenes on the growth and the induction of differentiation associated properties in K562 human erythroleukaemia cells has been investigated. Only 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one and a monomethyltriazene induced the formation of benzidine-positive cells, and a linear relationship was observed between growth inhibition and the percentage of haemoglobin producing cells in the culture. However, growth inhibition alone was insufficient for induction of haemoglobin synthesis since other members of the series inhibited growth without substantially increasing the number of haemoglobin-producing cells. Induction was accompanied by an increase in cell size, and appeared not to arise by selective toxicity to the original non-differentiated cell compartment followed by clonal expansion of the differentiated cells. These results suggest that methylating agents are more effective than ethylating agents in the alteration of gene expression.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3859296     DOI: 10.1016/0006-2952(85)90398-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  3 in total

1.  Role of protein kinase C in adriamycin-induced erythroid differentiation of K562 cells.

Authors:  R Hoffman; E S Newlands
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

2.  Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide.

Authors:  L L Tsang; C P Quarterman; A Gescher; J A Slack
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

3.  Antitumour imidazotetrazines--XI: Effect of 8-carbamoyl-3-methylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one [CCRG 81045; M and B 39831 NSC 362856] on poly(ADP-ribose) metabolism.

Authors:  M J Tisdale
Journal:  Br J Cancer       Date:  1985-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.